Measuring Fatigue in Multiple Sclerosis: There may be Trouble Ahead

INTRODUCTION: Poorly developed patient-reported outcome measures (PROs) risk type-II errors (i.e. false negatives) in clinical trials, resulting in erroneous failure to achieve trial endpoints. Validity is a fundamental requirement of fit-for-purpose PROs, with the main determinant of validity being...

Descripción completa

Detalles Bibliográficos
Autores principales: Close, James, Vandercappellen, Jo, King, Miriam, Hobart, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444927/
https://www.ncbi.nlm.nih.gov/pubmed/37353721
http://dx.doi.org/10.1007/s40120-023-00501-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444927/
https://www.ncbi.nlm.nih.gov/pubmed/37353721
http://dx.doi.org/10.1007/s40120-023-00501-9

Ejemplares similares